MicroPort Scientific Corporation has announced a transaction involving its indirect wholly-owned subsidiary, Shanghai Latent. On May 14, 2025, Shanghai Latent entered into a Block Trade Agreement with Placing Agents to dispose of certain assets. This strategic move is part of MicroPort's continuous efforts to innovate and expand its global reach in high-end medical devices, which include cardiovascular, orthopedics, and other specialized medical equipment. The transaction highlights MicroPort's commitment to enhancing its presence in the medical device industry through strategic asset management.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。